GRIN2B and Anxiety: This study demonstrated that B[a]P orally administered over a short period of exposure (10 days) causes changes in anxiety and memory-related behaviours and in Nmda receptor Nr1, Nr2a and Nr2b subunit gene expression in different brain areas involved in these cognitive behavioural functions.